upadacitinib
abbvie
[' uc ', 'upadacitinib', 'ibd']
 efficacy of upadacitinib dose escalation in p-iii lte uc study. #uegw2022 #ibd - dose escalation from 15 to 30 mg associated with improved efficacy outcomes
- start with 30 mg except for pts with risk factor?? 
Professor of Medicine, Gastroenterologist, specializing in the care of patients with IBD.
National representative of Germany @ https://t.co/Qr0PthTmU8 ex @Y_ECCO_IBD chair